These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6770097)

  • 21. Deactivation of the effects of F-Met-Leu-Phe and leukotriene B4 on calcium mobilization in rabbit neutrophils.
    Sha'afi RI; Molski TF; Borgeat P; Naccache PH
    Biochem Biophys Res Commun; 1981 Nov; 103(2):766-73. PubMed ID: 6277317
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutrophil hyperpolarization in response to a chemotactic peptide.
    Lazzari KG; Proto P; Simons ER
    J Biol Chem; 1990 Jul; 265(19):10959-67. PubMed ID: 2162827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of cyclic adenosine-3',5'-monophosphate in human polymorphonuclear leukocytes after surface stimulation.
    Smolen JE; Korchak HM; Weissmann G
    J Clin Invest; 1980 May; 65(5):1077-85. PubMed ID: 6245105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Movement of polymorphonuclear leukocytes: an elastimetry analysis.
    Cheung AT; Miller ME; Kawaoka EJ
    Biomater Med Devices Artif Organs; 1983; 11(1):53-61. PubMed ID: 6615997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin is a competitive inhibitor of the binding of the chemotactic peptide formyl-Met-Leu-Phe to human polymorphonuclear leukocytes.
    Abita JP
    Agents Actions; 1981 Dec; 11(6-7):610-2. PubMed ID: 6803537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of arachidonic acid and the chemotactic factor F-Met-Leu-Phe on cation transport in rabbit neutrophils.
    Sha'afi RI; Naccache PH; Alobaidi T; Molski TF; Volpi M
    J Cell Physiol; 1981 Feb; 106(2):215-23. PubMed ID: 7217212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similarities in the mechanisms by which formyl-methionyl-leucyl-phenylalanine, arachidonic acid and leukotriene B4 increase calcium and sodium influxes in rabbit neutrophils.
    Molski TF; Naccache PH; Borgeat P; Sha'afi RI
    Biochem Biophys Res Commun; 1981 Nov; 103(1):227-32. PubMed ID: 6274342
    [No Abstract]   [Full Text] [Related]  

  • 29. Phloretin is a potent inhibitor of rabbit neutrophil activation by chemotactic factors.
    Shefcyk J; Molski TF; Volpi M; Naccache PH; Sha'afi RI
    Biochim Biophys Acta; 1983 Feb; 728(1):97-102. PubMed ID: 6830775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma membrane potential modulates chemotactic peptide-stimulated cytosolic free Ca2+ changes in human neutrophils.
    Di Virgilio F; Lew PD; Andersson T; Pozzan T
    J Biol Chem; 1987 Apr; 262(10):4574-9. PubMed ID: 2435712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotaxin-induced changes in cyclic adenosine monophosphate levels in human neutrophils.
    Marx RS; McCall CE; Bass DA
    Infect Immun; 1980 Jul; 29(1):284-6. PubMed ID: 6249759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
    Opitz W; Fruchtmann R
    Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretagogue modulation of the response of human neutrophils to chemoattractants: studies with a membrane potential sensitive cyanine dye.
    Seligmann B; Gallin JI
    Mol Immunol; 1980 Feb; 17(2):191-200. PubMed ID: 6771522
    [No Abstract]   [Full Text] [Related]  

  • 36. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH; Molski TF; Volpi M; Mackin WM; Becker EL; Sha'afi RI
    J Cell Physiol; 1983 Jun; 115(3):243-8. PubMed ID: 6406520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unconjugated bile acids modulate adult and neonatal neutrophil chemotaxis induced in vitro by N-formyl-met-leu-phe-peptide.
    Santoro P; Raimondi F; Annunziata S; Paludetto R; Annella T; Ciccimarra F
    Pediatr Res; 2002 Mar; 51(3):392-6. PubMed ID: 11861947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of human neutrophilic chemotaxis by echo virus, type 9. Virus-induced changes in membrane fluidity.
    Bültmann B; Melzner I; Haferkamp O; Gruler H
    Pathol Res Pract; 1982; 175(2-3):308-11. PubMed ID: 7182838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.